慢性乙型肝炎（Chronic hepatitis B,CHB）感染影响2.96亿人，主要在亚太地区，每年估计有82万人死于肝硬化和肝细胞癌（hepatocellular ...

治疗组的复发时间明显长于安慰剂组（P ... results in phase 3 trial evaluating Caplyta for the prevention of relapse in patients with schizophrenia. News release. Intra-Cellular ...